Growth hormone response to clonidine in central and peripheral primary autonomic failure
- 1 August 1992
- journal article
- Published by Elsevier in The Lancet
- Vol. 340 (8814) , 263-266
- https://doi.org/10.1016/0140-6736(92)92355-j
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Hemodynamic and neurohormonal effects of clonidine in patients with preganglionic and postganglionic sympathetic lesions. Evidence for a central sympatholytic action.Circulation, 1991
- Functional and autoradiographic studies to locate the sites at which clonidine acts to cause hyperglycaemia and inhibition of opiate-induced sympathetic outflowNeuropharmacology, 1990
- Intravenous morphine causes hypertension, hyperglycaemia and increases sympatho-adrenal outflow in conscious rabbitsClinical Science, 1988
- Growth hormone and cortisol secretion after oral clonidine in healthy adultsPsychoneuroendocrinology, 1986
- Growth Hormone Response to Clonidine is Impaired in Patients with Central Sympathetic DegenerationClinical and Experimental Hypertension. Part A: Theory and Practice, 1984
- Effect of Clonidine on Growth Hormone and Glucagon SecretionHormone and Metabolic Research, 1981
- The Fourth Lilly Prize Lecture, University of Aberdeen, September 1980. The clinical pharmacology of clonidine and related central antihypertensive agents.British Journal of Clinical Pharmacology, 1981
- Impaired growth hormone secretion in the adult population: relation to age and adiposity.Journal of Clinical Investigation, 1981
- ORAL CLONIDINE AS A GROWTH HORMONE STIMULATION TESTThe Lancet, 1979
- The central hypotensive effect of clonidine; Studies in tetraplegie subjcetsClinical Pharmacology & Therapeutics, 1977